These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.

This document has been updated: Version 15 March 2022.

For translations of this document in other languages, click here.

Related document:


Archived versions:

  • Position paper
  • AstraZeneca COVID-19 vaccine
  • SAGE
  • COVID-19